Discovery and optimization of orally bioavailable and potent plasma Kallikrein inhibitors bearing a quaternary carbon-Reference-Cited by-同舟云学术

Discovery and optimization of orally bioavailable and potent plasma Kallikrein inhibitors bearing a quaternary carbon

Published:2022-11 Issue: Volume:73 Page:117035
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Zhang Weihe^ORCID,Vadlakonda Satish,Wu Minwan,Chintareddy Venkat,Vogeti LN,Juarez Luis,Muppa Saritha,Parker Cynthia,Kellogg-Yelder Debra,Williams Jason,Polach Kevin,Chen Xilin,Raman Krishnan,Babu Y.S.,Kotian Pravin

Funder

BioCryst

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference47 articles.

1. US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema;Busse;J Allergy Clin Immunol Pract,2021

2. Hereditary angioedema: Epidemiology and burden of disease;Lumry;Allergy Asthma Proc,2020

3. Oral plasma kallikrein inhibitor BCX7353 for treatment of hereditary angioedema;Hwang;Immunotherapy,2019

4. Mutational spectrum of the C1INH (SERPING1) gene in patients with hereditary angioedema;Gösswein;Cytogenet Genome Res,2008

5. Treatment of hereditary angioedema: a review;Bhardwaj;Transfusion,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on lipophilic efficiency as an important metric in drug design;Expert Opinion on Drug Discovery;2024-06-26

2. Fluorine in the pharmaceutical industry: Synthetic approaches and application of clinically approved fluorine-enriched anti-infectious medications;European Journal of Medicinal Chemistry;2024-05

3. Introduction to special issue on rare disease drug discovery;Bioorganic & Medicinal Chemistry;2023-09